RecruitingNCT06184581
Lithium versus lamotrigine for mood stability in bipolarity II
About this title
Lithium Versus Lamotrigine in Bipolar Disorder, Type II
Read the official source — NCT06184581Medication studyAges 18–70Denmark
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
- Listed locations
- CopenhagenSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 8, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 200
- Sponsor
- University Hospital Bispebjerg and Frederiksberg
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Denmark
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT06184581
- Official title
Show the full official title
Lithium Versus Lamotrigine in Bipolar Disorder, Type II - a Single Blinded Randomized Controlled Trial (the LiLa-Bipolar RCT)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Copenhagen
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospital Bispebjerg and Frederiksberg, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Lithium Carbonate and lamotrigine.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
